Emily Mullin

GLP-1 drugs like Ozempic are injectable medications—but a strange new market has emerged selling oral “compounded” versions online, despite a lack of evidence that they work.

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder. It’s finally being infused into patients.

San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors’ bone marrow in recent months.

More than two years after a historic Supreme Court decision ended the national right to an abortion, some states are fighting back—but the future of abortion rights remains in doubt.

Robert F. Kennedy Jr. says he’ll make big changes in the US government if Donald Trump is elected. He may find them hard to pull off, no matter what position he’s appointed to.

Science Corporation's retinal implant allowed some people who lost their central vision to read, play cards, and recognize faces.

Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do safely. It’s the latest escalation in a brewing war between pharmaceutical companies and compounders.

Thousands may now be at risk of mold-related illnesses following this year's hurricanes in the American South.

A Tampa-based company that makes atmospheric water generators and the state of Florida were able to supply one to a hospital shortly after Milton made landfall.

More than 200 health care facilities in impacted areas are moving patients and residents in what the state’s chief of emergency medical oversight calls “our largest evacuation ever.”